Stay updated with breaking news from Tom Graney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Interim Analysis for KALAHARI trial planned by Year-End 2022 with Full Top-Line Data Expected in Second half of 2023 Leuven, BELGIUM, Boston, MA, US - November 18, 2022 - 10:00
Negma Group has converted 130 convertible bonds in Oxurion resulting in a EUR 325,000 capital increase. This is part of Negma Group's EUR 30 million Capital Commitment1 that will allow Oxurion
Investegate announcements from Oxurion NV, Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA
Investegate announcements from Oxurion NV, Oxurion Receives Transparency Notification from Fidelity Management & Research Company LLC
Leuven, BELGIUM, Boston, MA, US - November 4, 2022 - 7 PM CET Oxurion NV(Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies